These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10563721)

  • 1. Severe anemia as a newly recognized side-effect caused by lamivudine.
    Weitzel T; Plettenberg A; Albrecht D; Lorenzen T; Stoehr A
    AIDS; 1999 Nov; 13(16):2309-11. PubMed ID: 10563721
    [No Abstract]   [Full Text] [Related]  

  • 2. Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.
    Tseng A; Conly J; Fletcher D; Keystone D; Salit I; Walmsley S
    Clin Infect Dis; 1998 Oct; 27(4):908-9. PubMed ID: 9798060
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiretroviral drugs and pregnancy: apropos of an alert regarding mitochondrial pathology and nucleoside analogs].
    Bavoux F; Loubeyre-Unique C; Blanche S
    Arch Pediatr; 2000 May; 7 Suppl 2():407s-408s. PubMed ID: 10904790
    [No Abstract]   [Full Text] [Related]  

  • 4. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
    Hester EK; Peacock JE
    AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine + lamivudine: new preparation. Fewer tablets required.
    Prescrire Int; 1999 Apr; 8(40):39-40. PubMed ID: 10848057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe skin rash with lamivudine in HIV infected patients: some unusual case reports.
    Modak D; Guha SK
    Indian J Pharmacol; 2013; 45(3):298-300. PubMed ID: 23833379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract]   [Full Text] [Related]  

  • 8. Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection.
    Williams LH; Fleckman P
    Br J Dermatol; 2007 Jan; 156(1):163-4. PubMed ID: 17199585
    [No Abstract]   [Full Text] [Related]  

  • 9. Triple nuke therapy--results after one year.
    TreatmentUpdate; 2001; 12(10):3-4. PubMed ID: 11570063
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opiates withdrawal syndrome after treatment with zidovudine + lamivudine + abcavir in patients with positivity for HIV and treated with methadone].
    Pardo López MA; Cuadrado Pastor JM; Pérez Hervás MP; Fernández Villalba E
    Rev Clin Esp; 2003 Aug; 203(8):407-8. PubMed ID: 12855129
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete reversibility of severe nucleoside-induced lipodystrophy.
    Strobel M; Muller P; Claudel P
    AIDS; 1999 Dec; 13(18):2606-7. PubMed ID: 10630538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symptomatic hyperlactemia in patients infected with the human immunodeficiency virus treated with nucleoside analogs].
    Lozano F; Ramayo E; Corzo JE; Gómez-Mateos J
    Med Clin (Barc); 2001 Jun; 117(1):36. PubMed ID: 11440700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe anemia in the framework of zidovudine treatment in HIV disease].
    Kis L; Heitzmann F; Keusch G; Möddel M
    Praxis (Bern 1994); 2006 Jan; 95(4):119-22. PubMed ID: 16485608
    [No Abstract]   [Full Text] [Related]  

  • 15. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial and peroxisomal dysfunction following perinatal exposure to antiretroviral drugs.
    Stojanov S; Wintergerst U; Belohradsky BH; Rolinski B
    AIDS; 2000 Jul; 14(11):1669. PubMed ID: 10983660
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term safety and efficacy of nevirapine, stavudine and lamivudine in a real-world setting.
    Shalit P; Farrell P; Lindgren P
    AIDS; 2001 Apr; 15(6):804-5. PubMed ID: 11371699
    [No Abstract]   [Full Text] [Related]  

  • 20. Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors.
    Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):159-65. PubMed ID: 17358025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.